These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15591552)

  • 21. [Hemochromatosis].
    Moirand R
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B68-78. PubMed ID: 10891767
    [No Abstract]   [Full Text] [Related]  

  • 22. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for hereditary hemochromatosis].
    Birgens HS; Hansen NE
    Ugeskr Laeger; 2002 Jun; 164(23):3083-4; discussion 3084-5. PubMed ID: 12082869
    [No Abstract]   [Full Text] [Related]  

  • 24. [Screening for hereditary hemochromatosis?].
    Møller P
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1044-5; author reply 1045. PubMed ID: 15852086
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening tests: problems with DNA-based insurance testing.
    Kaback M
    J Insur Med; 1993; Suppl B():237-46. PubMed ID: 10146359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Screening for hereditary hemochromatosis?].
    Asberg A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):15. PubMed ID: 15643454
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost containment and reproductive autonomy: prenatal genetic screening and the American Health Security Act of 1993.
    Morris DT
    Am J Law Med; 1994; 20(3):295-316. PubMed ID: 7702076
    [No Abstract]   [Full Text] [Related]  

  • 29. Insurance for the insurers. The use of genetic tests.
    Kass NE
    Hastings Cent Rep; 1992; 22(6):6-11. PubMed ID: 1428853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic discrimination in health insurance.
    Egan LE
    Spec Law Dig Health Care Law; 1999 May; (242):9-19. PubMed ID: 10537645
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemochromatosis: the importance of mutation screening in the family].
    ter Braak N; Erdkamp FL; van Deursen CT
    Ned Tijdschr Geneeskd; 2009 Apr; 153(16):765-7. PubMed ID: 19469149
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic testing for HFE gene mutations related to hereditary hemochromatosis.
    Tecnologica MAP Suppl; 2001 Dec; ():20-5. PubMed ID: 11933937
    [No Abstract]   [Full Text] [Related]  

  • 33. Colon cancer runs in my family: Should I get a genetic test? I worry that'll affect my insurance.
    Consum Rep; 2017 Jan; 82(1):21. PubMed ID: 27987532
    [No Abstract]   [Full Text] [Related]  

  • 34. Ending the genetic discrimination barrier: regaining confidence in preconception, prenatal, and neonatal genetic testing.
    Lovejoy W
    South Calif Law Rev; 2001 Mar; 74(3):873-901. PubMed ID: 16437819
    [No Abstract]   [Full Text] [Related]  

  • 35. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic knowledge among participants of a German pilot study on hemochromatosis screening.
    Stuhrmann M; Nippert I; Hoy L; Schmidtke J
    Clin Genet; 2006 Jul; 70(1):73-7. PubMed ID: 16813609
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis.
    Nisselle AE; Delatycki MB; Collins V; Metcalfe S; Aitken MA; du Sart D; Halliday J; Macciocca I; Wakefield A; Hill V; Gason A; Warner B; Calabro V; Williamson R; Allen KJ
    Clin Genet; 2004 May; 65(5):358-67. PubMed ID: 15099342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prioritisation of genetic screening with primary haemochromatosis as an example].
    de Craen AJ; van Aken MO; Westendorp RG
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1442-5. PubMed ID: 12908344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of ironXS: a study of the acceptability and feasibility of genetic screening for hereditary hemochromatosis in high schools.
    Delatycki MB; Wolthuizen M; Collins V; Varley E; Craven J; Allen KJ; Aitken MA; Bond L; Lockhart PJ; Wilson GR; Macciocca I; Metcalfe SA
    Clin Genet; 2010 Mar; 77(3):241-8. PubMed ID: 19930418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Euroscreen 2: towards community policy on insurance, commercialization and public awareness.
    Chadwick R; ten Have H; Hoedemaekers R; Husted J; Levitt M; McGleenan T; Shickle D; Wiesing U
    J Med Philos; 2001 Jun; 26(3):263-72. PubMed ID: 11445881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.